1st Choice Healthcare | |
308 Highway 62 W Ash Flat AR 72513-9415 | |
(870) 994-2202 | |
(870) 994-2328 |
Full Name | 1st Choice Healthcare |
---|---|
Speciality | Clinic/Center |
Location | 308 Highway 62 W, Ash Flat, Arkansas |
Authorized Official Name and Position | Sydney Stevens (CHIEF OPERATING OFFICER) |
Authorized Official Contact | 8708573334 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
1st Choice Healthcare Po Box 83 Corning AR 72422-0083 Ph: (870) 857-3334 | 1st Choice Healthcare 308 Highway 62 W Ash Flat AR 72513-9415 Ph: (870) 994-2202 |
NPI Number | 1962824672 |
---|---|
Provider Enumeration Date | 01/15/2014 |
Last Update Date | 12/14/2023 |
Medicare PECOS PAC ID | 0648184218 |
---|---|
Medicare Enrollment ID | O20140325000766 |
News Archive
A study by the Centers for Disease Control and Prevention concluded that adults younger than 65 were more likely than older Americans to skip medicines, or not take them as prescribed.
A new Tel Aviv University study examined the brain's reactions in conditions of uncertainty and stressful conflict in an environment of risks and opportunities.
In South Africa - "the quality of health care, including access to HIV prevention and testing services," largely depends on which of the country's 52 districts a resident lives in - according to findings in the latest District Health Barometer (DHB), an annual report by Health Systems Trust, IRIN reports. "Some of the inequities highlighted by the [report] can be traced to differences in health spending," IRIN writes.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange reported today that a significant decrease in HCV viral load was detected in 3 patients with liver cancer who are treated daily orally with CF102. The company is studying CF102 as a treatment for liver cancer (hepatocellular carcinoma, or HCC). The results announced today relate to data which came out of a Phase 1/2 clinical trial of CF102 in the treatment of patients with advanced HCC.
In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood, although gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the September 6 issue of JAMA.
› Verified 2 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1962824672 | NPI | - | NPPES |
205760749 | Medicaid | AR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
A study by the Centers for Disease Control and Prevention concluded that adults younger than 65 were more likely than older Americans to skip medicines, or not take them as prescribed.
A new Tel Aviv University study examined the brain's reactions in conditions of uncertainty and stressful conflict in an environment of risks and opportunities.
In South Africa - "the quality of health care, including access to HIV prevention and testing services," largely depends on which of the country's 52 districts a resident lives in - according to findings in the latest District Health Barometer (DHB), an annual report by Health Systems Trust, IRIN reports. "Some of the inequities highlighted by the [report] can be traced to differences in health spending," IRIN writes.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange reported today that a significant decrease in HCV viral load was detected in 3 patients with liver cancer who are treated daily orally with CF102. The company is studying CF102 as a treatment for liver cancer (hepatocellular carcinoma, or HCC). The results announced today relate to data which came out of a Phase 1/2 clinical trial of CF102 in the treatment of patients with advanced HCC.
In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood, although gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the September 6 issue of JAMA.
› Verified 2 days ago
Bradley Bibb Md Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 49 Highway 62 412, Ash Flat, AR 72513 Phone: 870-994-7301 | |
D/b/a Brmc Ash Flat Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 970 Ash Flat Dr, Ash Flat, AR 72513 Phone: 870-994-7301 Fax: 870-994-7488 | |
Brmc Ash Flat Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 970 Ash Flat Dr, Ash Flat, AR 72513 Phone: 870-994-7301 |